CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Price, Quote, News and Overview

What is the stock price of CORBUS PHARMACEUTICALS HOLDI today?

The current stock price of CRBP is 8.18 USD. The price decreased by -1.21% in the last trading session.

What is the ticker symbol for CORBUS PHARMACEUTICALS HOLDI stock?

The exchange symbol of CORBUS PHARMACEUTICALS HOLDI is CRBP and it is listed on the Nasdaq exchange.

On which exchange is CRBP stock listed?

CRBP stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for CORBUS PHARMACEUTICALS HOLDI stock?

15 analysts have analysed CRBP and the average price target is 57.91 USD. This implies a price increase of 607.99% is expected in the next year compared to the current price of 8.18. Check the CORBUS PHARMACEUTICALS HOLDI stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is CORBUS PHARMACEUTICALS HOLDI worth?

CORBUS PHARMACEUTICALS HOLDI (CRBP) has a market capitalization of 99.63M USD. This makes CRBP a Micro Cap stock.

How many employees does CORBUS PHARMACEUTICALS HOLDI have?

CORBUS PHARMACEUTICALS HOLDI (CRBP) currently has 19 employees.

What are the support and resistance levels for CORBUS PHARMACEUTICALS HOLDI (CRBP) stock?

CORBUS PHARMACEUTICALS HOLDI (CRBP) has a resistance level at 9.82. Check the full technical report for a detailed analysis of CRBP support and resistance levels.

Should I buy CORBUS PHARMACEUTICALS HOLDI (CRBP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CRBP, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CRBP, evaluating the profitability, health, valuation and growth aspects
• CORBUS PHARMACEUTICALS HOLDI (CRBP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• CORBUS PHARMACEUTICALS HOLDI (CRBP) Sales and EPS estimates to see what analysts future expectations are.
• CORBUS PHARMACEUTICALS HOLDI (CRBP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• CORBUS PHARMACEUTICALS HOLDI (CRBP) Insider and Institutional Ownership to learn about the owners and their transactions.
• CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Chart to make your own analysis
• CORBUS PHARMACEUTICALS HOLDI (CRBP) Latest news and press-releases to stay up to date.

Does CORBUS PHARMACEUTICALS HOLDI (CRBP) stock pay dividends?

CRBP does not pay a dividend.

When does CORBUS PHARMACEUTICALS HOLDI (CRBP) report earnings?

CORBUS PHARMACEUTICALS HOLDI (CRBP) will report earnings on 2025-03-10, after the market close.

What is the Price/Earnings (PE) ratio of CORBUS PHARMACEUTICALS HOLDI (CRBP)?

CORBUS PHARMACEUTICALS HOLDI (CRBP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.69).

What is the Short Interest ratio of CORBUS PHARMACEUTICALS HOLDI (CRBP) stock?

The outstanding short interest for CORBUS PHARMACEUTICALS HOLDI (CRBP) is 21.01% of its float. Check the ownership tab for more information on the CRBP short interest.

ChartMill assigns a fundamental rating of 1 / 10 to CRBP. CRBP has a bad profitability rating. Also its financial health evaluation is rather negative.

Over the last trailing twelve months CRBP reported a non-GAAP Earnings per Share(EPS) of -4.69. The EPS increased by 57.17% compared to the year before.

ChartMill assigns a Buy % Consensus number of 85% to CRBP. The Buy consensus is the average rating of analysts ratings from 15 analysts.